Douglas Fraser‐Pitt

413 total citations
20 papers, 343 citations indexed

About

Douglas Fraser‐Pitt is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Endocrinology. According to data from OpenAlex, Douglas Fraser‐Pitt has authored 20 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 4 papers in Pathology and Forensic Medicine and 4 papers in Endocrinology. Recurrent topics in Douglas Fraser‐Pitt's work include Cystic Fibrosis Research Advances (9 papers), Biomedical Research and Pathophysiology (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). Douglas Fraser‐Pitt is often cited by papers focused on Cystic Fibrosis Research Advances (9 papers), Biomedical Research and Pathophysiology (4 papers) and Amino Acid Enzymes and Metabolism (3 papers). Douglas Fraser‐Pitt collaborates with scholars based in United Kingdom, United States and Norway. Douglas Fraser‐Pitt's co-authors include Deborah A. O′Neil, Derry K. Mercer, David G. Smith, Neil F. Inglis, Graham Devereux, Benedikt M. Kessler, Anneke Lubben, Cédric Charrier, Daniel W. Smith and Dai Wang and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Douglas Fraser‐Pitt

19 papers receiving 329 citations

Peers

Douglas Fraser‐Pitt

PRM

EPIDE

ENDOC

James A. D. Good Sweden

Michael W. Dougherty United States

Xianwei Yang China

Yingzi Fan China

Amanda Miller United States

Sebastian Dintner Germany

Zhao Wei China

Mayo Yasugi Japan

Asma Haque Pakistan

Ana Serna‐Gallego Spain

James A. D. Good Sweden

Douglas Fraser‐Pitt

188 ×1.6

26 ×0.3

PRM

45 ×0.9

84 ×1.6

EPIDE

65 ×1.3

ENDOC

Citations per year, relative to Douglas Fraser‐Pitt Douglas Fraser‐Pitt (= 1×) peers James A. D. Good

Countries citing papers authored by Douglas Fraser‐Pitt

Since Specialization

Citations

This map shows the geographic impact of Douglas Fraser‐Pitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Fraser‐Pitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Fraser‐Pitt more than expected).

Fields of papers citing papers by Douglas Fraser‐Pitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Fraser‐Pitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Fraser‐Pitt. The network helps show where Douglas Fraser‐Pitt may publish in the future.

Co-authorship network of co-authors of Douglas Fraser‐Pitt

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Fraser‐Pitt. A scholar is included among the top collaborators of Douglas Fraser‐Pitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Fraser‐Pitt. Douglas Fraser‐Pitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fraser‐Pitt, Douglas, et al.. (2023). Cysteamine-mediated blockade of the glycine cleavage system modulates epithelial cell inflammatory and innate immune responses to viral infection. Biochemical and Biophysical Research Communications. 677. 168–181. 4 indexed citations

Fraser‐Pitt, Douglas, Stephen K. Dolan, Daniel W. Smith, et al.. (2021). Cysteamine Inhibits Glycine Utilisation and Disrupts Virulence in Pseudomonas aeruginosa. Frontiers in Cellular and Infection Microbiology. 11. 718213–718213. 13 indexed citations

Mercer, Derry K., et al.. (2021). Antimicrobial immunotherapeutics: past, present and future. Emerging Topics in Life Sciences. 5(5). 609–628. 4 indexed citations

Devereux, Graham, Stephen Bourke, Cori Daines, et al.. (2020). Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial. PLoS ONE. 15(12). e0242945–e0242945. 9 indexed citations

Devereux, G., S. Bourke, Cori Daines, et al.. (2019). WS12-6 Evaluating appropriate PROMs in CARE-CF-1 trial: Lynovex® (cysteamine) an oral adjunct to SOC interventions in cystic fibrosis infectious exacebations. Journal of Cystic Fibrosis. 18. S23–S24. 1 indexed citations

McLean, Kevin, Javier Palarea‐Albaladejo, Carol Currie, et al.. (2018). Rapid and robust analytical protocol for E. coli STEC bacteria subspecies differentiation using whole cell MALDI mass spectrometry. Talanta. 182. 164–170. 7 indexed citations

Fraser‐Pitt, Douglas, Derry K. Mercer, Daniel W. Smith, et al.. (2018). Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial Infection. Infection and Immunity. 86(6). 24 indexed citations

Devereux, Graham, Douglas Fraser‐Pitt, Seonaidh Cotton, et al.. (2016). An Open-Label Investigation of the Pharmacokinetics and Tolerability of Oral Cysteamine in Adults with Cystic Fibrosis. Clinical Drug Investigation. 36(8). 605–612. 18 indexed citations

Fraser‐Pitt, Douglas, et al.. (2016). Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex. Antimicrobial Agents and Chemotherapy. 60(10). 6200–6206. 15 indexed citations

10.

Devereux, Graham, Seonaidh Cotton, Douglas Fraser‐Pitt, et al.. (2015). 141 An open label investigation of the tolerability and pharmacokinetics of oral cysteamine in adults with cystic fibrosis. Journal of Cystic Fibrosis. 14. S93–S93. 3 indexed citations

11.

Devereux, Graham, et al.. (2015). Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum. EBioMedicine. 2(10). 1507–1512. 30 indexed citations

12.

Fraser‐Pitt, Douglas & Deborah A. O′Neil. (2015). Cystic Fibrosis – a Multiorgan Protein Misfolding Disease. Future Science OA. 1(2). FSO57–FSO57. 25 indexed citations

13.

Charrier, Cédric, et al.. (2014). Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis. Orphanet Journal of Rare Diseases. 9(1). 189–189. 53 indexed citations

14.

O′Neil, Deborah A. & Douglas Fraser‐Pitt. (2014). Progress Towards Next-Generation Therapeutics for Cystic Fibrosis. Future Medicinal Chemistry. 6(9). 1067–1079. 1 indexed citations

15.

Mercer, Derry K., et al.. (2014). 46 Ex vivo efficacy of Lynovex®, a next generation tri-functional candidate cystic fibrosis therapy. Journal of Cystic Fibrosis. 13. S58–S58. 1 indexed citations

16.

Fraser‐Pitt, Douglas, Pamela Cameron, Tom N. McNeilly, et al.. (2011). Phosphorylation of the epidermal growth factor receptor (EGFR) is essential for interleukin-8 release from intestinal epithelial cells in response to challenge with Escherichia coli O157 : H7 flagellin. Microbiology. 157(8). 2339–2347. 9 indexed citations

17.

Inglis, Neil F., et al.. (2010). Characterisation of proteins extracted from the surface of Salmonella Typhimurium grown under SPI‐2‐inducing conditions by LC‐ESI/MS/MS sequencing. PROTEOMICS. 11(3). 361–370. 13 indexed citations

18.

Burgess, Karl, Lisa Imrie, Douglas Fraser‐Pitt, et al.. (2009). Performance of five different electrospray ionisation sources in conjunction with rapid monolithic column liquid chromatography and fast MS/MS scanning. PROTEOMICS. 9(6). 1720–1726. 5 indexed citations

19.

Roe, Andrew J., Luke Tysall, Dai Wang, et al.. (2007). Analysis of the expression, regulation and export of NleA–E in Escherichia coli O157 : H7. Microbiology. 153(5). 1350–1360. 40 indexed citations

20.

Inglis, Neil F., et al.. (2006). Ultra‐fast tandem mass spectrometry scanning combined with monolithic column liquid chromatography increases throughput in proteomic analysis. Rapid Communications in Mass Spectrometry. 20(14). 2074–2080. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact